SEC Comment Letter 0000000000-24-004254 to BIOLARGO, INC. (BLGO)
BIOLARGO, INC.
Date: April 18, 2024 · CIK: 0000880242 · Accession: 0000000000-24-004254
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278669
Letter
United States securities and exchange commission logo April 18, 2024 Dennis P. Calvert Chief Executive Officer BioLargo, Inc. 14921 Chestnut St. Westminster, CA 92683 Re:BioLargo, Inc. Registration Statement on Form S-1 Filed April 12, 2024 File No. 333-278669 Dear Dennis P. Calvert: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Juan Grana at 202-551-6034 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Gilbert Bradshaw, Esq.
Show Raw Text
United States securities and exchange commission logo
April 18, 2024
Dennis P. Calvert
Chief Executive Officer
BioLargo, Inc.
14921 Chestnut St.
Westminster, CA 92683
Re:BioLargo, Inc.
Registration Statement on Form S-1
Filed April 12, 2024
File No. 333-278669
Dear Dennis P. Calvert:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Juan Grana at 202-551-6034 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Gilbert Bradshaw, Esq.